Table 1. Peripherally Acting Anti-Obesity Drug Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Peripherally Acting Anti-Obesity Drug Market Restraints

Table 3. Peripherally Acting Anti-Obesity Drug Market Trends

Table 4. Peripherally Acting Anti-Obesity Drug Industry Policy

Table 5. Global Peripherally Acting Anti-Obesity Drug Revenue by Company, 2019-2024, US$ million

Table 6. Global Peripherally Acting Anti-Obesity Drug Revenue Market Share by Company, 2019-2024

Table 7. Global Peripherally Acting Anti-Obesity Drug Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share by Company, 2019-2024

Table 9. Global Peripherally Acting Anti-Obesity Drug Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Peripherally Acting Anti-Obesity Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Peripherally Acting Anti-Obesity Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global Peripherally Acting Anti-Obesity Drug Manufacturers Product Type

Table 13. China Peripherally Acting Anti-Obesity Drug Revenue by Company, 2019-2024, US$ million

Table 14. China Peripherally Acting Anti-Obesity Drug Revenue Market Share by Company, 2019-2024

Table 15. China Peripherally Acting Anti-Obesity Drug Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Peripherally Acting Anti-Obesity Drug Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Peripherally Acting Anti-Obesity Drug Import & Export Trends

Table 19. Main Sources of China Peripherally Acting Anti-Obesity Drug Import

Table 20. Export Destination of China Peripherally Acting Anti-Obesity Drug

Table 21. Global Headquarters and Manufacturing Base of Peripherally Acting Anti-Obesity Drug Manufacturers

Table 22. Global Major Manufacturers, Peripherally Acting Anti-Obesity Drug Capacity Expansion and Future Plans

Table 23. Global Peripherally Acting Anti-Obesity Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Peripherally Acting Anti-Obesity Drug Production by Region, 2019-2024, (K Units)

Table 25. Global Peripherally Acting Anti-Obesity Drug Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Peripherally Acting Anti-Obesity Drug Upstream (Raw Materials)

Table 27. Global Peripherally Acting Anti-Obesity Drug Typical Customers

Table 28. Peripherally Acting Anti-Obesity Drug Typical Distributors

Table 29. By Type, Global Peripherally Acting Anti-Obesity Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Peripherally Acting Anti-Obesity Drug Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Peripherally Acting Anti-Obesity Drug Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Peripherally Acting Anti-Obesity Drug Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030

Table 37. By Country, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030

Table 39. Novo Nordisk A/S Company Information, Head Office, Market Area and Industry Position

Table 40. Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 41. Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Novo Nordisk A/S Company Profile and Main Business

Table 43. Novo Nordisk A/S Recent Developments

Table 44. Pfizer Inc. Company Information, Head Office, Market Area and Industry Position

Table 45. Pfizer Inc. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 46. Pfizer Inc. Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Pfizer Inc. Company Profile and Main Business

Table 48. Pfizer Inc. Recent Developments

Table 49. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area and Industry Position

Table 50. Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 51. Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Boehringer Ingelheim International GmbH Company Profile and Main Business

Table 53. Boehringer Ingelheim International GmbH Recent Developments

Table 54. KVK Tech Inc. Company Information, Head Office, Market Area and Industry Position

Table 55. KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 56. KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. KVK Tech Inc. Company Profile and Main Business

Table 58. KVK Tech Inc. Recent Developments

Table 59. Gelesis Holdings Company Information, Head Office, Market Area and Industry Position

Table 60. Gelesis Holdings Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 61. Gelesis Holdings Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Gelesis Holdings Company Profile and Main Business

Table 63. Gelesis Holdings Recent Developments

Table 64. Vivus LLC. Company Information, Head Office, Market Area and Industry Position

Table 65. Vivus LLC. Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 66. Vivus LLC. Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Vivus LLC. Company Profile and Main Business

Table 68. Vivus LLC. Recent Developments

Table 69. Currax Pharmaceuticals LLC Company Information, Head Office, Market Area and Industry Position

Table 70. Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 71. Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Currax Pharmaceuticals LLC Company Profile and Main Business

Table 73. Currax Pharmaceuticals LLC Recent Developments

Table 74. GlaxoSmithKline plc Company Information, Head Office, Market Area and Industry Position

Table 75. GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 76. GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. GlaxoSmithKline plc Company Profile and Main Business

Table 78. GlaxoSmithKline plc Recent Developments

Table 79. CHEPLAPHARM Arzneimittel GmbH Company Information, Head Office, Market Area and Industry Position

Table 80. CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 81. CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. CHEPLAPHARM Arzneimittel GmbH Company Profile and Main Business

Table 83. CHEPLAPHARM Arzneimittel GmbH Recent Developments

Table 84. Rhythm Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 85. Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Models, Specifications and Application

Table 86. Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Rhythm Pharmaceuticals Company Profile and Main Business

Table 88. Rhythm Pharmaceuticals Recent Developments

List of Figure

Figure 1. Peripherally Acting Anti-Obesity Drug Picture

Figure 2. By Revenue, Global Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Peripherally Acting Anti-Obesity Drug Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Peripherally Acting Anti-Obesity Drug Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Peripherally Acting Anti-Obesity Drug Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Peripherally Acting Anti-Obesity Drug Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Peripherally Acting Anti-Obesity Drug Share of Global Market, 2019-2030

Figure 10. Global Peripherally Acting Anti-Obesity Drug Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 11. Global Peripherally Acting Anti-Obesity Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2024

Figure 12. China Peripherally Acting Anti-Obesity Drug Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 13. China Peripherally Acting Anti-Obesity Drug Key Participants, Market Share, 2021 VS 2024 VS 2024

Figure 14. China Peripherally Acting Anti-Obesity Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Peripherally Acting Anti-Obesity Drug Domestic VS Export, 2024

Figure 16. Global Peripherally Acting Anti-Obesity Drug Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Peripherally Acting Anti-Obesity Drug Capacity Market Share by Region, 2024 VS 2030

Figure 18. Global Peripherally Acting Anti-Obesity Drug Production Market Share & Forecast by Region, 2019-2030

Figure 19. Peripherally Acting Anti-Obesity Drug Industry Chain

Figure 20. Peripherally Acting Anti-Obesity Drug Procurement Model

Figure 21. Peripherally Acting Anti-Obesity Drug Sales Model

Figure 22. Peripherally Acting Anti-Obesity Drug Sales Channels, Direct Sales and Distribution

Figure 23. Prescription Drugs

Figure 24. Non-prescription Drugs

Figure 25. By Type, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030

Figure 27. By Type, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Peripherally Acting Anti-Obesity Drug Price, 2019-2030, (US$/Unit)

Figure 30. Hospital Pharmacies

Figure 31. Retail Pharmacies

Figure 32. Online Pharmacies

Figure 33. By Application, Global Peripherally Acting Anti-Obesity Drug Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030

Figure 35. By Application, Global Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Peripherally Acting Anti-Obesity Drug Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2019-2030

Figure 39. By Region, Global Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2019-2030

Figure 40. North America Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024

Figure 42. Europe Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024

Figure 44. Asia Pacific Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024

Figure 46. South America Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2024

Figure 48. Middle East & Africa Peripherally Acting Anti-Obesity Drug Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 51. By Type, U.S. Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 52. By Application, U.S. Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 53. Europe Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 55. By Type, Europe Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 56. By Application, Europe Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 57. China Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 59. By Type, China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 60. By Application, China Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 61. Japan Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 63. By Type, Japan Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 64. By Application, Japan Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 65. South Korea Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 67. By Type, South Korea Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 68. By Application, South Korea Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 69. Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 71. By Type, Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 72. By Application, Southeast Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 73. India Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 75. By Type, India Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 76. By Application, India Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 77. Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Peripherally Acting Anti-Obesity Drug Market Share, 2024

Figure 79. By Type, Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 80. By Application, Middle East & Asia Peripherally Acting Anti-Obesity Drug Sales Volume Market Share, 2024 VS 2030

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches